| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Retrospective Study |
| Article Title |
Role of serological rapid antibody test in the management of possible COVID-19 cases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fatma Yıldırım, Pinar Yildiz Gulhan, Özlem Ercen Diken, Aylin Capraz, Meltem Şimsek, Berna Botan Yildirim, Muhammet Ridvan Taysi, Sakine Yilmaz Ozturk, Nurcan Demirtas, Julide Ergil, Adem Dirican, Tugce Uzar, Irem Karaman and Sevket Ozkaya |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sevket Ozkaya, MD, Associate Professor, Doctor, Doctor, Department of Pulmonary Medicine, Bahcesehir University, Faculty of Medicine, Sahrayı Cedit District, Batman Street, No. 66, 34734 Kadıköy, Istanbul 34734, Türkiye. ozkayasevket@yahoo.com |
| Key Words |
COVID-19; Rapid antibody test; Reverse transcription polymerase chain reaction; High resolution computed tomography; Serology; Pneumonia |
| Core Tip |
This is the first clinical retrospective study in Turkey that reports the features of the patients that were diagnosed and treated as possible coronavirus disease 2019 (COVID-19) cases whose multiple nasopharyngeal swab samples were negative by reverse transcription polymerase chain reaction (RT-PCR) but serological immunoglobulin M/immunoglobulin G antibody against severe acute respiratory syndrome coronavirus 2 was detected by a rapid antibody test. Our study demonstrated the feasibility of COVID-19 diagnosis based on rapid antibody tests in the cases of patients whose RT-PCR samples were negative. An effective diagnosis for COVID-19 is likely to require a hybrid strategy of PCR and serologic testing with the radiological demonstration. |
| Publish Date |
2021-09-16 08:41 |
| Citation |
Yıldırım F, Gulhan PY, Diken ÖE, Capraz A, Şimsek M, Yildirim BB, Taysi MR, Ozturk SY, Demirtas N, Ergil J, Dirican A, Uzar T, Karaman I, Ozkaya S. Role of serological rapid antibody test in the management of possible COVID-19 cases. World J Exp Med 2021; 11(4): 44-54 |
| URL |
https://www.wjgnet.com/2220-315x/full/v11/i4/44.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v11.i4.44 |
